Head and neck squamous cell carcinoma in FAMMM syndrome

Head and Neck

Volumn 31, Issue 11, 2009, Pages 1524-1527

  Vinarsky, Vladimir ^a   Fine, Robert L ^a,b   Assaad, Adel ^a   Qian, Ying ^a   Chabot, John A ^a,b   Su, Gloria H ^a,b   Frucht, Harold ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

Familial HNSCC; FAMMM syndrome; FAMMM PC; Germline INK4a mutation; Pancreatic cancer

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; DNA SEQUENCE; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILY HISTORY; GENE MUTATION; HUMAN; MALE; MELANOMA; ONSET AGE; PANCREAS CANCER; PRIORITY JOURNAL; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

ADULT; CARCINOMA, SQUAMOUS CELL; DYSPLASTIC NEVUS SYNDROME; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOMA; PANCREATIC NEOPLASMS; PEDIGREE; YOUNG ADULT;

EID: 70350348720     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21050     Document Type: Article

References (13)

1. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-823.
2. Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET. Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 1996;88:1489-1491. (Pubitemid 26340052)
3. Yu KK, Zanation AM, Moss JR, Yarbrough WG. Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope 2002;112:1587-11193
4. Oldenburg RA, de Vos tot Nederveen Cappel WH, van Puijenbroek M, et al. Extending the p16-Leiden tumour spectrum by respiratory tract tumours. J Med Genet 2004;41:e31.
5. Goldstein AM. Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat 2004;23:630.
6. Parry D, Peters G. Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma. Mol Cell Biol 1996;16:3844-3852. (Pubitemid 26199904)
7. Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995;333:975-977.
8. Yarbrough WG. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Laryngoscope 2002;112:2114-2128. (Pubitemid 35417032)
9. Soufir N, Avril MF, Chompret A, et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet 1998;7:209-216. (Pubitemid 28048536)
10. Della Torre G, Pasini B, Frigerio S, et al. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Br J Cancer 2001;85:836-844. (Pubitemid 33010550)
11. Goldstein AM, Chidambaram A, Halpern A, et al. Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res 2002;12:51-55. (Pubitemid 34183689)
12. Sun S, Pollock PM, Liu L, et al. CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein. Int J Cancer 1997;73:531-536. (Pubitemid 28005317)
13. Schneider-Stock R, Giers A, Motsch C, et al. Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors. Am J Hum Genet 2003;72:216-218. (Pubitemid 36061248)